Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Piramal | Healthcare

Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Piramal | Healthcare
247 Business Park, A - Wing, 6th Floor, LBS Marg, Vikhroli (West), Mumbai, Maharashtra, 400083, India
022-30956893
Contact Piramal | Healthcare
Website

 Latest Content from PMHub 

Video: Self-pay and Emerging Markets

White Papers and Resources | August 12, 2016 | Inizio

A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

News: Therapy Watch HCV expands into 4 additional EU markets

White Papers and Resources | August 12, 2016 | Inizio

The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...

News: Research Partnership launches new patient report – Living with Ulcerative Colitis

White Papers and Resources | August 12, 2016 | Inizio

Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain...

Summer Intern experience at Research Partnership

White Papers and Resources | August 12, 2016 | Inizio

We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research

Health Unlimited announces partnership with HealthUnlocked to expand direct-to-consumer insight and engagement

Press Releases | August 12, 2016 | Health Unlimited

London, 12th August 2016. Health Unlimited, the specialist healthcare marketing communications group, part of Creston Unlimited, today announces a global partnership agreement with HealthUnlocked.

What kind of customer data are you getting?

White Papers and Resources | August 10, 2016 | Anthill Agency

How to collect the proper data to discover how to act next.

Products as portfolios: positioning immuno-oncology products

White Papers and Resources | August 9, 2016 | Blue Latitude Health

The last few years have seen a huge proliferation in the number of products entering the oncology space, with a lot more currently being investigated in clinical trials. Effective positioning...

Making a difference together

Press Releases | August 8, 2016 | Lucid Group Communications Limited

It was highlighted at the 2016 World Economic Forum that ‘good business’ now means more than financial success, with multiple stakeholders asking how business will benefit society. At Lucid, our...

Immunotherapy in oncology

White Papers and Resources | August 5, 2016 | Blue Latitude Health

Consultant David Cooney explores the medical insights, unmet needs, and future of the vastly growing area of immunotherapy as the fourth pillar in oncology.

European prostate cancer treatment is changing – what are the opportunities for marketers?

White Papers and Resources | August 5, 2016 | Blue Latitude Health

Consultant Jeremy Poland examines some of the key dynamics in prostate cancer multi-disciplinary teams across Europe and how the recent trends impact the opportunities available to healthcare marketers.